Core Viewpoint - ACM Research (ACMR) anticipates revenues between 950 million for 2025, reflecting approximately 18% growth at the mid-point compared to the revised estimated range of 770 million for 2024 [1][2]. Group 1: Revenue Drivers - Strong demand for ACMR's wafer processing solutions is the primary growth driver, with continued investments from Mainland China customers expected to sustain robust demand [2]. - The company expects manageable impacts from U.S. component export restrictions on its supply chain [2]. Group 2: Market Position and Product Offerings - ACMR's cleaning business, which includes single wafer cleaning and semi-critical clinical equipment, is utilized in 90% of all cleaning process steps, addressing a significant market worth approximately 5 billion, while the non-China SAM is estimated at 3 billion in revenues over the long term and has expanded production capacity with a new facility in Oregon [13]. Group 4: Financial Performance and Stock Analysis - The Zacks Consensus Estimate for 2025 earnings is set at $1.80 per share, remaining unchanged over the past 30 days, with ACMR having beaten earnings estimates in the last four quarters [14]. - ACMR shares are currently trading above the 50-day and 200-day moving averages, indicating a bullish trend [16]. - The stock is trading at a discount, with a forward 12-month Price/Sales ratio of 1.13X, lower than its median of 1.41X and the sector's 6.88X [18].
ACMR's 2025 Top-Line View is Impressive: Buy or Hold the Stock?